Literature DB >> 24789162

Hepatitis E-associated encephalopathy in a renal transplant recipient.

Marijke A de Vries1, Johnny P A Samijn, Rob de Man, Johannes M M Boots.   

Abstract

Hepatitis E virus genotype 3 is not rare in developed countries, and may cause chronic hepatitis in immunocompromised patients. This may not only lead to abnormalities in liver test and malaise, but to severe neurological symptoms as well. In this case, chronic hepatitis E infection caused encephalopathy, an atactic gait, Lhermitte's sign, incomplete bladder emptying and peripheral sensory neuropathy in a renal transplant recipient. The diagnosis was not performed until years after the onset of first symptoms and several months after the onset of neurological symptoms. If treated adequately, viral load can be reduced in over two-thirds of patients and neurological symptoms are often resolved. More widespread knowledge about this virus and its extrahepatic manifestations may lead to a quicker diagnosis, and may limit pathology. Serological screening should be added to standard pretransplant virological screening, so that, in the future, patients without antibodies could be vaccinated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789162      PMCID: PMC4025397          DOI: 10.1136/bcr-2014-204244

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Hepatitis E.

Authors:  Jay H Hoofnagle; Kenrad E Nelson; Robert H Purcell
Journal:  N Engl J Med       Date:  2012-09-27       Impact factor: 91.245

2.  Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012.

Authors:  E Slot; B M Hogema; A Riezebos-Brilman; T M Kok; M Molier; H L Zaaijer
Journal:  Euro Surveill       Date:  2013-08-01

Review 3.  Hepatitis E.

Authors:  Nassim Kamar; Richard Bendall; Florence Legrand-Abravanel; Ning-Shao Xia; Samreen Ijaz; Jacques Izopet; Harry R Dalton
Journal:  Lancet       Date:  2012-04-30       Impact factor: 79.321

4.  Safety and efficacy of a recombinant hepatitis E vaccine.

Authors:  Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

Review 5.  Hepatitis E: an emerging infection in developed countries.

Authors:  Harry R Dalton; Richard Bendall; Samreen Ijaz; Malcolm Banks
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

6.  Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts.

Authors:  Hugo Wéclawiack; Nassim Kamar; Marion Mehrenberger; Céline Guilbeau-Frugier; Anne Modesto; Jacques Izopet; David Ribes; Federico Sallusto; Lionel Rostaing
Journal:  Nephrol Dial Transplant       Date:  2007-10-03       Impact factor: 5.992

7.  A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route.

Authors:  Keiji Matsubayashi; Jong-Hon Kang; Hidekatsu Sakata; Kazuaki Takahashi; Motohiro Shindo; Masaru Kato; Shinichiro Sato; Toshiaki Kato; Hiroyuki Nishimori; Kunihiko Tsuji; Hiroyuki Maguchi; Jun-Ichi Yoshida; Hiroshi Maekubo; Shunji Mishiro; Hisami Ikeda
Journal:  Transfusion       Date:  2008-07       Impact factor: 3.157

Review 8.   Review of the neurological manifestations of hepatitis E infection.

Authors:  Michelle C M Cheung; James Maguire; Ivana Carey; Julia Wendon; Kosh Agarwal
Journal:  Ann Hepatol       Date:  2012 Sep-Oct       Impact factor: 2.400

Review 9.  Hepatitis E virus and neurologic disorders.

Authors:  Nassim Kamar; Richard P Bendall; Jean Marie Peron; Pascal Cintas; Laurent Prudhomme; Jean Michel Mansuy; Lionel Rostaing; Frances Keane; Samreen Ijaz; Jacques Izopet; Harry R Dalton
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

10.  Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France.

Authors:  Florence Legrand-Abravanel; Nassim Kamar; Karine Sandres-Saune; Sebastien Lhomme; Jean-Michel Mansuy; Fabrice Muscari; Federico Sallusto; Lionel Rostaing; Jacques Izopet
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more
  5 in total

Review 1.  Hepatitis E virus and neurological injury.

Authors:  Harry R Dalton; Nassim Kamar; Jeroen J J van Eijk; Brendan N Mclean; Pascal Cintas; Richard P Bendall; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2015-12-29       Impact factor: 42.937

Review 2.  Mystery of hepatitis e virus: recent advances in its diagnosis and management.

Authors:  Aftab Ahmed; Ijlal Akbar Ali; Hira Ghazal; Javid Fazili; Salman Nusrat
Journal:  Int J Hepatol       Date:  2015-01-19

Review 3.  Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature.

Authors:  Fateh Bazerbachi; Samir Haffar; Sushil K Garg; John R Lake
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-09-10

Review 4.  A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection.

Authors:  Prashanth Rawla; Jeffrey Pradeep Raj; Alan Jose Kannemkuzhiyil; John Sukumar Aluru; Krishna Chaitanya Thandra; Mahesh Gajendran
Journal:  Med Sci (Basel)       Date:  2020-02-04

5.  Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients.

Authors:  Antonio Rivero-Juarez; Nicolau Vallejo; Pedro Lopez-Lopez; Ana Isabel Díaz-Mareque; Mario Frias; Aldara Vallejo; Javier Caballero-Gómez; María Rodríguez-Velasco; Esther Molina; Antonio Aguilera
Journal:  Microorganisms       Date:  2019-12-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.